Neuroprotective effects of granulocyte-colony stimulating factor in a novel transgenic mouse model of SCA17

Journal of Neurochemistry

Volumn 118, Issue 2, 2011, Pages 288-303

  Chang, Ya Chin ^a   Lin, Cheng Yueh ^a   Hsu, Chen Ming ^a   Lin, Hsin Chieh ^a   Chen, Yu Hsiang ^a   Lee Chen, Guey Jen ^a   Su, Ming Tsan ^a   Ro, Long Sun ^b   Chen, Chiung Mei ^b   Hsieh Li, Hsiu Mei ^a  

^a NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

cerebellum; G CSF; Purkinje cell; SCA17; spinocerebellar ataxia

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; TATA BINDING PROTEIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATAXIA; BEHAVIORAL SCIENCE; CONTROLLED STUDY; GENE; GENE MUTATION; GLIOSIS; HTBP GENE; INFLAMMATION; MOUSE; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PCP2 GENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PURKINJE CELL; ROTAROD TEST; SPINOCEREBELLAR ATAXIA TYPE 17; SPINOCEREBELLAR DEGENERATION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MICE; MICE, TRANSGENIC; NEUROPROTECTIVE AGENTS; PHENOTYPE; SPINOCEREBELLAR ATAXIAS; TATA-BOX BINDING PROTEIN;

MUS; MUS MUSCULUS;

EID: 79960007952     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07304.x     Document Type: Article

References (86)

1. Barski J. J., Hartmann J., Rose C. R., Hoebeek F., Morl K., Noll-Hussong M., De Zeeuw C. I., Konnerth A., and, Meyer M., (2003) Calbindin in cerebellar Purkinje cells is a critical determinant of the precision of motor coordination. J. Neurosci. 23, 3469-3477. (Pubitemid 36531989)
2. Bianchi M., Fone K. F., Azmi N., Heidbreder C. A., Hagan J. J., and, Marsden C. A., (2006) Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus. Eur. J. Neurosci. 24, 2894-2902. (Pubitemid 44813840)
3. Bodine D. M., Seidel N. E., Gale M. S., Nienhuis A. W., and, Orlic D., (1994) Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 84, 1482-1491. (Pubitemid 24273016)
4. Borchelt D. R., Davis J., Fischer M., et al. (1996) A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet. Anal. 13, 159-163. (Pubitemid 27063321)
5. Bowman A. B., Yoo S. Y., Dantuma N. P., and, Zoghbi H. Y., (2005) Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum. Mol. Genet. 14, 679-691. (Pubitemid 40309593)
6. Boy J., Schmidt T., Wolburg H., et al. (2009) Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3. Hum. Mol. Genet. 18, 4282-4295.
7. Brown L. J., Koza R. A., Marshall L., Kozak L. P., and, MacDonald M. J., (2002) Lethal hypoglycemic ketosis and glyceroluria in mice lacking both the mitochondrial and the cytosolic glycerol phosphate dehydrogenases. J. Biol. Chem. 277, 32899-32904. (Pubitemid 34984803)
8. Bruni A. C., Takahashi-Fujigasaki J., Maltecca F., et al. (2004) Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. Arch. Neurol. 61, 1314-1320. (Pubitemid 39062691)
9. Burright E. N., Clark H. B., Servadio A., Matilla T., Feddersen R. M., Yunis W. S., Duvick L. A., Zoghbi H. Y., and, Orr H. T., (1995) SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82, 937-948.
10. Burright E. N., Orr H. T., and, Clark H. B., (1997) Mouse models of human CAG repeat disorders. Brain Pathol. 7, 965-977. (Pubitemid 27346737)
11. Cao X. Q., Arai H., Ren Y. R., et al. (2006) Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2/Bax expression levels. J. Neurochem. 99, 861-867. (Pubitemid 44583445)
12. Carlsson G., Ahlin A., Dahllof G., Elinder G., Henter J. I., and, Palmblad J., (2004) Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia. Br. J. Haematol. 126, 127-132. (Pubitemid 38859493)
13. Carter R. J., Lione L. A., Humby T., Mangiarini L., Mahal A., Bates G. P., Dunnett S. B., and, Morton A. J., (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19, 3248-3257. (Pubitemid 29174016)
14. Chai Y., Koppenhafer S. L., Shoesmith S. J., Perez M. K., and, Paulson H. L., (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8, 673-682. (Pubitemid 29139983)
15. Davies S. W., Turmaine M., Cozens B. A., Raza A. S., Mahal A., Mangiarini L., and, Bates G. P., (1999) From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease. Philos. Trans. R Soc. Lond. B Biol. Sci. 354, 981-989.
16. DeLegge M. H., and, Smoke A., (2008) Neurodegeneration and inflammation. Nutr. Clin. Pract. 23, 35-41. (Pubitemid 351438966)
17. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., and, Aronin N., (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993. (Pubitemid 27449140)
18. Douhou A., Debeir T., Michel P. P., Stankovski L., Oueghlani-Bouslama L., Verney C., and, Raisman-Vozari R., (2003) Differential activation of astrocytes and microglia during post-natal development of dopaminergic neuronal death in the weaver mouse. Brain Res. Dev. Brain Res. 145, 9-17. (Pubitemid 38368637)
19. Eddleston M., and, Mucke L., (1993) Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 54, 15-36. (Pubitemid 23147085)
20. Evert B. O., Vogt I. R., Kindermann C., Ozimek L., de Vos R. A., Brunt E. R., Schmitt I., Klockgether T., and, Wullner U., (2001) Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J. Neurosci. 21, 5389-5396. (Pubitemid 32692137)
21. Friedman M. J., Shah A. G., Fang Z. H., Ward E. G., Warren S. T., Li S., and, Li X. J., (2007) Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration. Nat. Neurosci. 10, 1519-1528. (Pubitemid 350175880)
22. Friedman M. J., Wang C. E., Li X. J., and, Li S., (2008) Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity. J. Biol. Chem. 283, 8283-8290.
23. Fujigasaki H., Martin J. J., De Deyn P. P., et al. (2001) CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain 124, 1939-1947. (Pubitemid 32945895)
24. Gantois I., Fang K., Jiang L., et al. (2007) Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior. Proc. Natl Acad. Sci. USA 104, 4182-4187. (Pubitemid 47181599)
25. Garden G. A., Libby R. T., Fu Y. H., et al. (2002) Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice. J. Neurosci. 22, 4897-4905. (Pubitemid 37465605)
26. Gomez C. M., (2001) Polyglutamine aggregates in SCA6 Purkinje cells: a tail of two toxicities. Neurology 56, 1618-1619. (Pubitemid 32574556)
27. Hagenah J. M., Zuhlke C., Hellenbroich Y., Heide W., and, Klein C., (2004) Focal dystonia as a presenting sign of spinocerebellar ataxia 17. Mov. Disord. 19, 217-220. (Pubitemid 38312707)
28. Harkins A. B., and, Fox A. P., (2002) Cell death in weaver mouse cerebellum. Cerebellum 1, 201-206. (Pubitemid 44133829)
29. Holmberg M., Duyckaerts C., Durr A., et al. (1998) Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum. Mol. Genet. 7, 913-918. (Pubitemid 28221256)
30. Hubner J., Sprenger A., Klein C., et al. (2007) Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17). Neurology 69, 1160-1168. (Pubitemid 47517562)
31. Huynh D. P., Figueroa K., Hoang N., and, Pulst S. M., (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat. Genet. 26, 44-50.
32. Klement I. A., Skinner P. J., Kaytor M. D., Yi H., Hersch S. M., Clark H. B., Zoghbi H. Y., and, Orr H. T., (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41-53. (Pubitemid 28458023)
33. Kocherlakota P., and, La Gamma E. F., (1997) Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics 100, E6.
34. Koda M., Nishio Y., Kamada T., et al. (2007) Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res. 1149, 223-231. (Pubitemid 46659901)
35. Koide R., Kobayashi S., Shimohata T., Ikeuchi T., Maruyama M., Saito M., Yamada M., Takahashi H., and, Tsuji S., (1999) A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum. Mol. Genet. 8, 2047-2053. (Pubitemid 29458732)
36. Komine-Kobayashi M., Zhang N., Liu M., Tanaka R., Hara H., Osaka A., Mochizuki H., Mizuno Y., and, Urabe T., (2006) Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J. Cereb. Blood Flow Metab. 26, 402-413.
37. Kondratova A. A., Dubrovsky Y. V., Antoch M. P., and, Kondratov R. V., (2010) Circadian clock proteins control adaptation to novel environment and memory formation. Aging (Albany NY) 2, 285-297.
38. Krause D. L., and, Muller N., (2010) Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int. J. Alzheimers Dis. 2010, 732806.
39. Lasek K., Lencer R., Gaser C., et al. (2006) Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain 129, 2341-2352. (Pubitemid 44522119)
40. Lee S. T., Chu K., Jung K. H., et al. (2005) Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res. 1058, 120-128. (Pubitemid 41416806)
41. Lee S. T., Park J. E., Kim D. H., et al. (2008) Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease. Brain Res. 1194, 130-137.
42. Lin I. S., Wu R. M., Lee-Chen G. J., Shan D. E., and, Gwinn-Hardy K., (2007) The SCA17 phenotype can include features of MSA-C PSP and cognitive impairment. Parkinsonism Relat. Disord. 13, 246-249. (Pubitemid 46603028)
43. Liu B., and, Hong J. S., (2003) Role of microglia in inflammation- mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304, 1-7. (Pubitemid 36008905)
44. Ma B., Zimmermann T., Rohde M., Winkelbach S., He F., Lindenmaier W., and, Dittmar K. E., (2007) Use of Autostitch for automatic stitching of microscope images. Micron 38, 492-499. (Pubitemid 46420676)
45. Manto M. U., (2005) The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum 4, 2-6.
46. Meuer K., Pitzer C., Teismann P., et al. (2006) Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J. Neurochem. 97, 675-686.
47. Nakamura K., Jeong S. Y., Uchihara T., Anno M., Nagashima K., Nagashima T., Ikeda S., Tsuji S., and, Kanazawa I., (2001) SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum. Mol. Genet. 10, 1441-1448. (Pubitemid 32684885)
48. Paulson H. L., (2009) The spinocerebellar ataxias. J. Neuroophthalmol. 29, 227-237.
49. Pekny M., Wilhelmsson U., Bogestal Y. R., and, Pekna M., (2007) The role of astrocytes and complement system in neural plasticity. Int. Rev. Neurobiol. 82, 95-111.
50. Reddy P. H., Williams M., Charles V., Garrett L., Pike-Buchanan L., Whetsell Jr W. O., Miller G., and, Tagle D. A., (1998) Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat. Genet. 20, 198-202. (Pubitemid 28455456)
51. Reetz K., Lencer R., Hagenah J. M., et al. (2010) Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17. Cerebellum 9, 210-217.
52. Reid S. J., Rees M. I., van Roon-Mom W. M., et al. (2003) Molecular investigation of TBP allele length: a SCA17 cellular model and population study. Neurobiol. Dis. 13, 37-45. (Pubitemid 36561596)
53. Rizzi M., Perego C., Aliprandi M., et al. (2003) Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol. Dis. 14, 494-503. (Pubitemid 37543527)
54. Rolfs A., Koeppen A. H., Bauer I., Bauer P., Buhlmann S., Topka H., Schols L., and, Riess O., (2003) Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann. Neurol. 54, 367-375. (Pubitemid 37072039)
55. Salminen A., Ojala J., Kauppinen A., Kaarniranta K., and, Suuronen T., (2009) Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog. Neurobiol. 87, 181-194.
56. Schabitz W. R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Scholzke M. N., Sommer C., and, Schwab S., (2003) Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34, 745-751. (Pubitemid 36307405)
57. Schilling G., Becher M. W., Sharp A. H., et al. (1999a) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. 8, 397-407. (Pubitemid 29097327)
58. Schilling G., Wood J. D., Duan K., et al. (1999b) Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron 24, 275-286. (Pubitemid 29466165)
59. Schilling G., Jinnah H. A., Gonzales V., et al. (2001) Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA. Neurobiol. Dis. 8, 405-418. (Pubitemid 32566132)
60. Schneider A., Kruger C., Steigleder T., et al. (2005a) The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 115, 2083-2098. (Pubitemid 41134150)
61. Schneider A., Kuhn H. G., and, Schabitz W. R., (2005b) A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 4, 1753-1757. (Pubitemid 41827320)
62. Sehara Y., Hayashi T., Deguchi K., et al. (2007) Potentiation of neurogenesis and angiogenesis by G-CSF after focal cerebral ischemia in rats. Brain Res. 1151, 142-149. (Pubitemid 46709859)
63. Shyu W. C., Lin S. Z., Yang H. I., Tzeng Y. S., Pang C. Y., Yen P. S., and, Li H., (2004) Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 110, 1847-1854. (Pubitemid 39299228)
64. Six I., Gasan G., Mura E., and, Bordet R., (2003) Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur. J. Pharmacol. 458, 327-328. (Pubitemid 36009473)
65. Solaroglu I., Cahill J., Jadhav V., and, Zhang J. H., (2006a) A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 37, 1123-1128.
66. Solaroglu I., Tsubokawa T., Cahill J., and, Zhang J. H., (2006b) Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 143, 965-974. (Pubitemid 44827523)
67. Sugama S., Takenouchi T., Cho B. P., Joh T. H., Hashimoto M., and, Kitani H., (2009) Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Inflamm. Allergy Drug Targets 8, 277-284.
68. Tabuchi M., Yamaguchi T., Iizuka S., Imamura S., Ikarashi Y., and, Kase Y., (2009) Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease. J. Ethnopharmacol. 122, 157-162.
69. Takahashi J., Tanaka J., Arai K., Funata N., Hattori T., Fukuda T., Fujigasaki H., and, Uchihara T., (2001) Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease. J. Neuropathol. Exp. Neurol. 60, 369-376. (Pubitemid 32274052)
70. Tang T. S., Tu H., Chan E. Y., Maximov A., Wang Z., Wellington C. L., Hayden M. R., and, Bezprozvanny I., (2003) Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 39, 227-239. (Pubitemid 36897546)
71. Taniguchi T., Doe N., Matsuyama S., Kitamura Y., Mori H., Saito N., and, Tanaka C., (2005) Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation. FEBS Lett. 579, 5704-5712. (Pubitemid 41460490)
72. Taylor J. P., Tanaka F., Robitschek J., Sandoval C. M., Taye A., Markovic-Plese S., and, Fischbeck K. H., (2003) Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 12, 749-757. (Pubitemid 36416961)
73. Tomomura M., Rice D. S., Morgan J. I., and, Yuzaki M., (2001) Purification of Purkinje cells by fluorescence-activated cell sorting from transgenic mice that express green fluorescent protein. Eur. J. Neurosci. 14, 57-63. (Pubitemid 32738474)
74. Toyoshima Y., Yamada M., Onodera O., Shimohata M., Inenaga C., Fujita N., Morita M., Tsuji S., and, Takahashi H., (2004) SCA17 homozygote showing Huntington's disease-like phenotype. Ann. Neurol. 55, 281-286. (Pubitemid 38167006)
75. Tsai K. J., Tsai Y. C., and, Shen C. K., (2007) G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J. Exp. Med. 204, 1273-1280.
76. Uchihara T., Fujigasaki H., Koyano S., Nakamura A., Yagishita S., and, Iwabuchi K., (2001) Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias - triple-labeling immunofluorescence study. Acta Neuropathol. 102, 149-152. (Pubitemid 32771662)
77. Wang W., Redecker C., Yu Z. Y., Xie M. J., Tian D. S., Zhang L., Bu B. T., and, Witte O. W., (2008) Rat focal cerebral ischemia induced astrocyte proliferation and delayed neuronal death are attenuated by cyclin-dependent kinase inhibition. J. Clin. Neurosci. 15, 278-285.
78. Wang C. J., Zhou Z. G., Holmqvist A., Zhang H., Li Y., Adell G., and, Sun X. F., (2009) Survivin expression quantified by Image Pro-Plus compared with visual assessment. Appl. Immunohistochem. Mol. Morphol. 17, 530-535.
79. Welte K., Reiter A., Mempel K., Pfetsch M., Schwab G., Schrappe M., and, Riehm H., (1996) A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Munster Study Group. Blood 87, 3143-3150.
80. Wullner U., and, Klockgether T., (2003) Inflammation in Parkinson's disease. J. Neurol. 250 (Suppl. 1), I35-I38. (Pubitemid 36255755)
81. Yan X. B., Wang S. S., Hou H. L., Ji R., and, Zhou J. N., (2007) Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav. Brain Res. 177, 282-289. (Pubitemid 46149907)
82. Yvert G., Lindenberg K. S., Picaud S., Landwehrmeyer G. B., Sahel J. A., and, Mandel J. L., (2000) Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice. Hum. Mol. Genet. 9, 2491-2506.
83. Zavala F., Abad S., Ezine S., Taupin V., Masson A., and, Bach J. F., (2002) G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J. Immunol. 168, 2011-2019. (Pubitemid 34135805)
84. Zhang X., Baader S. L., Bian F., Muller W., and, Oberdick J., (2001) High level Purkinje cell specific expression of green fluorescent protein in transgenic mice. Histochem. Cell Biol. 115, 455-464. (Pubitemid 32662420)
85. Zhao L. R., Navalitloha Y., Singhal S., Mehta J., Piao C. S., Guo W. P., Kessler J. A., and, Groothuis D. R., (2007) Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp. Neurol. 204, 569-573. (Pubitemid 46497044)
86. Zuhlke C., Hellenbroich Y., Dalski A., Kononowa N., Hagenah J., Vieregge P., Riess O., Klein C., and, Schwinger E., (2001) Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur. J. Hum. Genet. 9, 160-164. (Pubitemid 32237048)